Aptevo Therapeutics Inc (APVO) financials · $9.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Aptevo Therapeutics Inc (APVO) $9.9M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$26.3M | -$24.6M |
| Net Income | -$26.0M | -$24.1M |
| EPS (Diluted) | -$87.27 | -$87.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $27.2M | $15.6M |
| Current Assets | $23.1M | $10.7M |
| Cash & Equivalents | $21.6M | $8.71M |
| PP&E | $303.0K | $543.0K |
| Total Liabilities | $9.81M | $10.8M |
| Current Liabilities | $6.05M | $6.21M |
| Shareholders' Equity | $17.4M | $4.75M |
| Retained Earnings | -$275.1M | -$247.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$25.6M | -$23.8M |
| Investing Cash Flow | N/A | N/A |
| Financing Cash Flow | $38.5M | $15.6M |
| Net Change in Cash | $12.9M | -$8.19M |
FAQ
What is APVO P/E and revenue?
Aptevo Therapeutics Inc (APVO) $9.9M cap.
What is APVO revenue?
APVO income-statement cache has no revenue figure yet.
Is APVO profitable?
Aptevo Therapeutics Inc last cached net income is -$26.0M (FY2025).
What are APVO total assets?
Aptevo Therapeutics Inc last cached total assets are $27.2M (FY2025).
What is APVO free cash flow?
No cached cash-flow row for APVO yet.
Not investment advice. Cached statements, not a live tape.